Lunchtime seminar: When to say what to whom?

On April 13, you are welcome to the seminar "When to say what to whom - surviving as a life science company on the stock market".

Small companies in the life sciences sector all share a common challenge – funding. One route that steam takes is to take the company public through an IPO. This means that communication becomes a key issue for the company’s strategy.

Welcome to a seminar where an experienced panel of experts will explain the concepts!

lunchtime Narva

In the panels

Rein Piir. VP Investor relations at Camurus with long experience of IR issues from, among others, Medivir and Carnegie.

Linda Holmström. Brand and communications manager, Recipharm, who became communications manager with IR responsibilities overnight at the time of the IPO in 2014.

Per Wester. CEO of Alzinova, which had a successful IPO just before the end of the year.

Moderator: Ingrid Heath, Vice President and Head of Policy, SwedenBIO.

Among other things, the seminar will discuss
– What are the rules on communication when a company goes public?
– How does publicity affect the company’s operations?
– What does the increased public interest mean for company management?
– What are the advantages and disadvantages of being an audience member?

The seminar is organized in cooperation between SwedenBIO and Narva.

Practical info

When: Wednesday, April 13. Lunch will be served at 11.30, seminar at 12-13.

Location: Narva, Linnégatan 2, 5 stairs.

Register at ida.melin@narva.se, the seminar is free of charge.

Link to the invitation as pdf.